MODERN RHEUMATOLOGY, vol.25, no.4, pp.621-624, 2015 (SCI-Expanded)
Objectives. The aim of this report was to evaluate and discuss treatment of pediatric familial Mediterranean fever (FMF) patients with anti-interleukin1 (IL-1) agents.